Abstract
Background: Differences in isoflavone content of soy protein may explain the absence of a dose–response relation between soy protein intake and blood cholesterol concentrations.
Objective: To study specifically the effect of soy-associated isoflavones on cholesterol concentrations in well-controlled trials substituting soy protein with dairy or animal protein.
Design: Studies were identified by MEDLINE searches (1995 - 6 June 2002) and reviewing reference lists. Studies were included if they had a control group or treatment, experimental diets only differed in the amounts of soy protein and isoflavones and were each fed for at least 14 days. A total of 10 studies met these criteria, providing 21 dietary comparisons.
Subjects: Studies comprised 959 subjects (336 men and 623 women), average age ranged from 41 to 67 y and baseline cholesterol concentration from 5.42 to 6.60 mmol/l.
Interventions: The intake of soy-associated isoflavones increased by 1–95 mg/day and the intake of soy protein increased by 19–60 g/day.
Results: Feeding daily 36 g soy protein with 52 mg soy-associated isoflavones on average decreased low-density lipoprotein (LDL) cholesterol by −0.17±0.04 mmol/l (mean±s.e.) and increased high-density lipoprotein (HDL) cholesterol by 0.03±0.01 mmol/l. There was no dose–response relation between soy-associated isoflavones and changes in LDL cholesterol (R=−0.33, P=0.14) (Pearson correlation coefficient) or HDL cholesterol (R=−0.07, P=0.76) or their ratio.
Conclusions: Consumption of soy-associated isoflavones is not related to changes in LDL or HDL cholesterol.
Sponsorship: Unilever Research and Development, Vlaardingen, The Netherlands.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Anderson JW, Johnstone BM & Cook-Newell ME (1995): Meta-analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 333, 276–282.
Anthony MS, Blair RM & Clarkson TB (2002): Neither isoflavones nor the alcohol-extracted fraction added to alcohol-washed soy protein isolate restores the lipoprotein effects of soy protein isolate [abstract]. J. Nutr. 132, 583S.
Ashton E & Ball M (2000): Effects of soy as tofu vs meat on lipoprotein concentrations. Eur. J. Clin. Nutr. 54, 14–19.
Axelson M, Sjovall J, Gustafsson BE & Setchell KD (1984): Soya—a dietary source of the non-steroidal oestrogen equol in man and animals. J. Endocrinol. 102, 49–56.
Baum JA, Teng H, Erdman JW, Weigel RM, Klein BP, Persky VW, Freels S, Surya P, Bakhit RM, Ramos E, Shay NF & Potter SM (1998): Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am. J. Clin. Nutr. 68, 545–551.
Boden WE (2000): High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trial. Am. J. Cardiol. 86, 19L–22L.
Crouse JR, Morgan T, Terry JG, Ellis J, Vitolins M & Burke GL (1999): A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch. Intern. Med. 159, 2070–2076.
Dent SB, Peterson CT, Brace LD, Swain JH, Reddy MB, Hanson KB, Robinson JG & Alekel DL . (2001): Soy protein intake by perimenopausal women does not affect circulating lipids and lipoproteins or coagulation and fibrinolytic factors. J. Nutr. 131, 2280–2287.
Dewell A, Hollenbeck CB & Bruce B (2002): The effects of soy-derived phytoestrogens on serum lipids and lipoproteins in moderately hypercholesterolemic postmenopausal women. J. Clin. Endocrinol. Metab. 87, 118–121.
Egger M, Davey SG, Schneider M & Minder C (1997): Bias in meta-analysis detected by a simple, graphical test. Br. Med. J. 315, 629–634.
Erdman JW (2000): Soy protein and cardiovascular disease. A statement for healthcare professionals form the nutrition committee of the AHA. Circulation 102, 2555–2559.
Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (2001): National Cholesterol Education Program (NCEP) Adult Treatment Panel III Report. http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3_rpt.htm (10 December 2001).
Gardner CD, Newell KA, Cherin R & Haskell WL (2001): The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women. Am. J. Clin. Nutr. 73, 728–735.
Jenkins DJA, Kendall CWC, Jackson CJ, Connelly PW, Parker T, Faulkner D, Vidgen E, Cunnane SC, Leiter LA & Josse RG (2002): Effects of high and low isoflavone soy foods on blood lipids, oxidized LDL, homocysteine and blood pressure in hyperlipemic men and women. Am. J. Clin. Nutr. 76, 365–372
Kleinbaum DG, Kupper LL & Morgenstern H . (1988): Applied Regression Analysis and Other Multivariable Methods. 2nd edition. Belmont, Duxbury Press.
Laboratory Methods Committee of the Lipids Research Clinics Program (1977): Cholesterol and triglyceride concentrations in serum/plasma pairs. Clin. Chem. 23, 60–63.
Law M (2000): Plant sterol and stanol margarines and health. Br. Med. J. 320, 861–864.
Law MR, Wald NJ & Thompson SG (1994): By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? Brit. Med. J. 308, 367–372.
Lichtenstein AH . (2001): Got soy? Am. J. Clin. Nutr. 73, 667–668.
Meinertz H, Nilausen K & Hilden J (2002): Alcohol-extracted, but not intact, dietary soy protein lowers lipoprotein(a) markedly. Arterioscler.Thromb.Vasc. Biol. 22, 312–316.
Meyer BJ, Larkin TA, Owen AJ, Astheimer LB, Tapsell L & Howe PRC (2002): The hypocholesterolaemic effect of chronic soy supplementation may be linked to equol. (abstract) In: Proceedings of conference Soy & Health 2002. Clinical evidence—dietetic applications. May 30–31, 2002, London, UK.
Morito K, Hirose T, Kinjo J, Hirakawa T, Okawa M, Nohara T, Ogawa S, Inoue S, Muramatsu M & Masamune Y (2001): Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol. Pharm. Bull. 24, 351–356.
Oakenfull DG (2001): Soy protein, saponins and plasma cholesterol. J. Nutr. 131, 2971.
Potter SM (1995): Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J. Nutr. 125, 606S–611S.
Samman S, Lyons WPM, Chan GS, Smith SJ & Petocz P (1999): The effect of supplementation with isoflavones on plasma lipids and oxidisability of low density lipoprotein in premenopausal women. Atherosclerosis 147, 277–283.
Setchell KD, Borriello SP, Hulme P, Kirk DN & Axelson M (1984): Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am. J. Clin. Nutr. 40, 569–578.
Simons LA, von Konigsmark M, Simons J & Celermajer DS (2000): Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. Am. J. Cardiol. 85, 1297–1301.
Sirtori CR & Lovati MR (2001): Soy proteins and cardiovascular disease. Curr. Atheroscler. Rep 3, 47–53.
Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S & McGrath BP (2001): Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J. Clin. Endocrinol. Metab. 86, 3053–3060.
Teixeira SR, Potter SM, Weigel R, Hannum S, Erdman JW & Hasler CM (2000): Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. Am. J. Clin. Nutr. 71, 1077–1084.
Van Horn L, Liu K, Gerber J, Garside D, Schiffer L, Gernhofer N & Greenland P (2001): Oats and soy in lipid-lowering diets for women with hypercholesterolemia: is there synergy? J. Am. Diet. Assoc 101, 1319–1325.
Vigna GB Pansini F Bonaccorsi G Albertazzi P Donega P Zanotti L De Aloysio D Mollica G & Fellin R (2000): Plasma lipoproteins in soy-treated postmenopausal women: a double-blind, placebo-controlled trial. Nutr. Metab. Cardiovasc. Dis. 10, 315–322.
Vitolins MZ Anthony M & Burke GL (2001): Soy protein isoflavones, lipids and arterial disease. Curr. Opin. Lipidol. 12, 433–437.
Weggemans RM Zock PL & Katan MB (2001): Dietary cholesterol from eggs increases the ratio of total cholesterol to high-density lipoprotein cholesterol in man. A meta-analysis. Am. J. Clin. Nutr. 73, 885–891.
Author information
Authors and Affiliations
Contributions
Guarantor: RW Weggemans.
Corresponding author
Rights and permissions
About this article
Cite this article
Weggemans, R., Trautwein, E. Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis. Eur J Clin Nutr 57, 940–946 (2003). https://doi.org/10.1038/sj.ejcn.1601628
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1601628
Keywords
This article is cited by
-
Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?
Current Atherosclerosis Reports (2021)
-
Preventive effect of Elateriospermum tapos seed extract against obese Sprague Dawley rats
Advances in Traditional Medicine (2020)
-
Soy food and isoflavones are not associated with changes in serum lipids and glycohemoglobin concentrations among Japanese adults: a cohort study
European Journal of Nutrition (2020)
-
The association between urinary phytoestrogen excretion and components of the metabolic syndrome in NHANES
European Journal of Nutrition (2014)
-
Association of rs5888 SNP in the scavenger receptor class B type 1 gene and serum lipid levels
Lipids in Health and Disease (2012)